Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

François Bassompierre

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Transplantation|July 25, 2006
A grading system based on severity of infection to predict mortality in allogeneic stem cell transplant recipientsCatherine Cordonnier, Sébastien Maury, Patricia Ribaud, et al.
Annals of Internal Medicine|July 2, 2003
Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trialCatherine Cordonnier, Sylvie Chevret, Marc Legrand, et al.
Transplantation|June 30, 2004
Predicting the costs of allogeneic sibling stem-cell transplantation: results from a prospective, multicenter, French studyHélène Espérou, Alain Brunot, Françoise Roudot-Thoraval, et al.
Lancet (London, England)|January 26, 2002
Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trialBertrand Godeau, Sylvie Chevret, Bruno Varet, et al.
Therapie|July 10, 2016
[Not Available]Jean-François Dhainaut, François Bassompierre, Christophe Misse, et al.
Therapie|August 8, 2014
Promoting the place of the allied health professions in clinical researchMonique Rothan-Tondeur, Soizic Courcier, Jehan-Michel Béhier, et al.
Therapie|March 10, 2015
What strategy should France implement for H2020?Jean-François Dhainaut, Vincent Diebolt, Brigitte Pouletty-Lefèbvre, et al.
Therapie|July 10, 2016
[Not Available]Monique Rothan-Tondeur, Soizic Courcier, Jehan-Michel Béhier, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Transplantation|July 25, 2006
A grading system based on severity of infection to predict mortality in allogeneic stem cell transplant recipientsCatherine Cordonnier, Sébastien Maury, Patricia Ribaud, et al.
Annals of Internal Medicine|July 2, 2003
Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trialCatherine Cordonnier, Sylvie Chevret, Marc Legrand, et al.
Transplantation|June 30, 2004
Predicting the costs of allogeneic sibling stem-cell transplantation: results from a prospective, multicenter, French studyHélène Espérou, Alain Brunot, Françoise Roudot-Thoraval, et al.
Lancet (London, England)|January 26, 2002
Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trialBertrand Godeau, Sylvie Chevret, Bruno Varet, et al.
Therapie|July 10, 2016
[Not Available]Jean-François Dhainaut, François Bassompierre, Christophe Misse, et al.
Therapie|August 8, 2014
Promoting the place of the allied health professions in clinical researchMonique Rothan-Tondeur, Soizic Courcier, Jehan-Michel Béhier, et al.
Therapie|March 10, 2015
What strategy should France implement for H2020?Jean-François Dhainaut, Vincent Diebolt, Brigitte Pouletty-Lefèbvre, et al.
Therapie|July 10, 2016
[Not Available]Monique Rothan-Tondeur, Soizic Courcier, Jehan-Michel Béhier, et al.
Pageof 1